Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,482 | -7,933 | -18,490 | -16,444 | -11,445 |
| Depreciation Amortization | 89 | 24 | 475 | 481 | 208 |
| Accounts payable and accrued liabilities | 188 | -392 | -583 | 841 | -431 |
| Other Working Capital | 441 | -608 | 85 | 400 | 104 |
| Other Operating Activity | -37 | 665 | 1,041 | -265 | 1,030 |
| Operating Cash Flow | $-4,801 | $-8,244 | $-17,472 | $-14,987 | $-10,534 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -4 | -3 | -12 | -11 |
| Purchase Of Investment | N/A | N/A | -5,471 | -20,504 | N/A |
| Sale Of Investment | N/A | 3,050 | 18,400 | 4,102 | N/A |
| Investing Cash Flow | $-4 | $3,046 | $12,926 | $-16,414 | $-11 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,281 | 3,532 | 6,551 | N/A | 37,000 |
| Other Financing Activity | -721 | -428 | -704 | 0 | -3,007 |
| Financing Cash Flow | $6,560 | $3,104 | $5,847 | $N/A | $33,993 |
| Beginning Cash Position | 6,608 | 8,702 | 7,401 | 38,802 | 15,354 |
| End Cash Position | 8,363 | 6,608 | 8,702 | 7,401 | 38,802 |
| Net Cash Flow | $1,755 | $-2,094 | $1,301 | $-31,401 | $23,448 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,801 | -8,244 | -17,472 | -14,987 | -10,534 |
| Capital Expenditure | -4 | -4 | -3 | -12 | -11 |
| Free Cash Flow | -4,805 | -8,248 | -17,475 | -14,999 | -10,545 |